Antitumor activity of rituximab plus thalidomide in patients with relapsed/refractory mantle cell lymphoma.
Kaufmann H, Raderer M, W?hrer S, P?sp?k A, Bankier A, Zielinski C, Chott A, Drach J. Antitumor activity of rituximab plus thalidomide in patients with relapsed/refractory mantle cell lymphoma. Blood. 2004 Oct 15; 104(8):2269-71.